133 related articles for article (PubMed ID: 8020510)
1. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations.
Gallotti A; Uggeri F; Favilla A; Cabrini M; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S1-12. PubMed ID: 8020510
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility and safety profile of iomeprol.
Rosati G
Eur J Radiol; 1994 May; 18 Suppl 1():S120-4. PubMed ID: 8020514
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of safety and efficacy of iomeprol and iopamidol in carotid digital subtraction angiography.
Beltramello A; Piovan E; Rosta L
Eur J Radiol; 1994 May; 18 Suppl 1():S67-72. PubMed ID: 8020521
[TBL] [Abstract][Full Text] [Related]
4. Iomeprol: a review of its use as a contrast medium.
Dooley M; Jarvis B
Drugs; 2000 May; 59(5):1169-86. PubMed ID: 10852647
[TBL] [Abstract][Full Text] [Related]
5. Borate complexes of x-ray iodinated contrast agents: characterization and sorption studies for their removal from aqueous media.
Rustighi I; Donati I; Ferluga M; Campa C; Pasqua AE; Rossi M; Paoletti S
J Hazard Mater; 2012 Feb; 205-206():10-6. PubMed ID: 22245510
[TBL] [Abstract][Full Text] [Related]
6. [Stability of iodinated contrast media in UV-laser irradiation and toxicity of the photoproducts].
Grönewäller EF; Wahl HG; Kehlbach R; Rodemann HP; Claussen CD; Duda SH
Rofo; 1998 Nov; 169(5):537-41. PubMed ID: 9849607
[TBL] [Abstract][Full Text] [Related]
7. Formation of oxidation by-products of the iodinated X-ray contrast medium iomeprol during ozonation.
Seitz W; Jiang JQ; Schulz W; Weber WH; Maier D; Maier M
Chemosphere; 2008 Jan; 70(7):1238-46. PubMed ID: 17892892
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
Heinrich MC; Kuhlmann MK; Grgic A; Heckmann M; Kramann B; Uder M
Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795
[TBL] [Abstract][Full Text] [Related]
9. Iomeprol: current and future profile of a radiocontrast agent.
Katayama H; Spinazzi A; Fouillet X; Kirchin MA; Taroni P; Davies A
Invest Radiol; 2001 Feb; 36(2):87-96. PubMed ID: 11224756
[TBL] [Abstract][Full Text] [Related]
10. Viscosity of iodinated contrast agents during renal excretion.
Jost G; Lengsfeld P; Lenhard DC; Pietsch H; Hütter J; Sieber MA
Eur J Radiol; 2011 Nov; 80(2):373-7. PubMed ID: 21376497
[TBL] [Abstract][Full Text] [Related]
11. Multiple regression analysis of octanol/water partition coefficients of non-ionic monomeric radiographic contrast media with the combination of three molecular descriptors.
Violon D
Br J Radiol; 1999 Jan; 72(853):44-7. PubMed ID: 10341688
[TBL] [Abstract][Full Text] [Related]
12. Irradiation in presence of iodinated contrast agent results in radiosensitization of endothelial cells: consequences for computed tomography therapy.
Joubert A; Biston MC; Boudou C; Ravanat JL; Brochard T; Charvet AM; Estève F; Balosso J; Foray N
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1486-96. PubMed ID: 16029811
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of iomeprol for injection in experimental animals.
Cipolla P; Tirone P; Luzzani F; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S32-42. PubMed ID: 8020517
[TBL] [Abstract][Full Text] [Related]
14. Stability of nonionic water-soluble contrast media: implications for their design.
Sovak M; Ranganathan R
Invest Radiol; 1980; 15(6 Suppl):S323-8. PubMed ID: 7203944
[TBL] [Abstract][Full Text] [Related]
15. Multistep approach for the structural identification of biotransformation products of iodinated X-ray contrast media by liquid chromatography/hybrid triple quadrupole linear ion trap mass spectrometry and (1)H and (13)C nuclear magnetic resonance.
Kormos JL; Schulz M; Wagner M; Ternes TA
Anal Chem; 2009 Nov; 81(22):9216-24. PubMed ID: 19842634
[TBL] [Abstract][Full Text] [Related]
16. New non-ionic contrast: effects on the cardiovascular system.
Pagny JY; Gaux JC
Eur J Radiol; 1996 Nov; 23 Suppl 1():S2-5. PubMed ID: 9056156
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of selected iodinated X-ray contrast media and characterization of microbial transformation pathways.
Kormos JL; Schulz M; Kohler HP; Ternes TA
Environ Sci Technol; 2010 Jul; 44(13):4998-5007. PubMed ID: 20509647
[TBL] [Abstract][Full Text] [Related]
18. Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
Morisetti A; Tirone P; Luzzani F; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S21-31. PubMed ID: 8020516
[TBL] [Abstract][Full Text] [Related]
19. Molecular rearrangement of 5-(a-hydroxy-alkanoylamino)-2,4,6-triiodo-isophthalic acid amides.
Felder E; Gallotti A; Favilla A
Invest Radiol; 1988 Sep; 23 Suppl 1():S101-5. PubMed ID: 3198328
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tissue distribution of iomeprol in animals.
Lorusso V; Luzzani F; Bertani F; Tirone P; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S13-20. PubMed ID: 8020515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
